Papers
4
Total Citations
44
H-Index
2
About
Mark Mann is a urologic surgeon and researcher whose work centers on the intersection of surgical innovation, patient education, and pain management in minimally invasive urologic oncology. His most impactful contribution comes from a 2022 study on individualized 3D-printed models for robotic partial nephrectomies, which demonstrated significant improvements in both trainee and patient education as well as surgical planning—a paper that has already garnered 30 citations for its practical, translational value. Mann has also made important contributions to understanding the evolution of prostate cancer surgery, including a 2009 study examining how the shift to minimally invasive techniques altered patient risk profiles and a 2014 analysis of blood transfusion patterns following open versus robot-assisted radical prostatectomy. More recently, he has focused on combating the opioid crisis through a 2020 prospective trial showing that simple "opt-in" non-narcotic postoperative pain regimens can dramatically reduce opiate prescriptions after minimally invasive surgery without compromising pain control. Mann’s work consistently bridges surgical technique with patient-centered outcomes, demonstrating how thoughtful innovation can improve both clinical results and the patient experience.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4